User Guide for (2S,3R)-2-[[(2S)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoic acid (CAS 911813-90-6)
Table of Contents
1. Product Overview & Comparative Analysis
Key Specifications
Parameter | CAS 911813-90-6 | Competitor Compound X |
---|---|---|
Purity | ≥98% (HPLC) | ≥95% |
Solubility | DMSO, Ethanol | Limited aqueous solubility |
Storage | -20°C (desiccated) | 4°C (short-term) |
2. Detailed Applications
Primary Use Cases
- Pharmaceutical intermediate for kinase inhibition studies
- Biochemical probe for lipid metabolism research
- Key component in peptide-based drug development
3. Usage Scenarios
Typical Experimental Protocols
- In Vitro Testing: 10-100μM concentration range in cell culture media
- Animal Models: 5mg/kg dosage in pharmacokinetic studies
- Analytical Methods: LC-MS quantification with C18 column (retention time 8.2min)
4. Client Case Studies
Case 1: Oncology Research Institute
Application: Investigated compound's anti-angiogenic properties in triple-negative breast cancer models
Result: 40% tumor growth inhibition at 50μM (p<0.05 vs control)
Case 2: Metabolic Disease Center
Application: Studied lipid-modifying effects in non-alcoholic steatohepatitis (NASH) models
Result: 25% reduction in hepatic triglycerides (8-week treatment)
Case 3: Contract Research Organization
Application: ADME profiling for preclinical candidate optimization
Result: Improved metabolic stability (t1/2 = 6.8h in human microsomes)
5. Technical Inquiry & Support
For bulk orders or custom synthesis requirements:
Email: info@vivalr.com
Tel: (86) 15866781826
Request additional documentation:
- Certificate of Analysis (CoA)
- Safety Data Sheets (SDS)
- Custom synthesis capabilities